# SODIUM PHENYLACETATE AND SODIUM BENZOATE
> **ANDA217526** · Abbreviated New Drug Application (Generic) · Sponsor: NAVINTA LLC · Approved 2023-07-14
## Drug
- **FDA Application Number:** ANDA217526
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** SODIUM PHENYLACETATE AND SODIUM BENZOATE
- **Generic name:** SODIUM PHENYLACETATE AND SODIUM BENZOATE
- **Active ingredients:** SODIUM BENZOATE; SODIUM PHENYLACETATE
- **Dosage form:** SOLUTION
- **Route:** INTRAVENOUS
- **Marketing status:** Prescription
- **Sponsor:** NAVINTA LLC
- **Manufacturer:** Zydus Pharmaceuticals USA Inc.
- **First approval:** 2023-07-14
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=217526)
---
*MORVS · CC0 1.0*